2 completed, 2 terminated. 2 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Iv Methylprednisolone: new trials by email Literature Review of Iv Methylprednisolone trials Research Report on Iv Methylprednisolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids - Acute-graft-versus-host Disease | Phase 1 / Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 10 | 2023-06-05 | 2026-03-24 |
| Rituximab (RTX) Therapy in Patients With Active TAO Rituximab, Iv Methylprednisolone, peroral methylprednisolone and Methotrexate - Ophthalmopathy, Thyroid-Associated | Phase 4 | Completed | Göteborg University | 38 | 2011-12-01 | 2025-03-26 |
| Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks megadose oral methylprednisolone, IV methylprednisolone - Multiple Sclerosis | Phase 3 | Terminated | Fred Lublin | 16 | 2003-09-01 | 2017-05-18 |
| AVONEX® Combination Trial - "ACT" Methotrexate, IV methylprednisolone - Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Completed | Biogen | 350 | 2003-06-01 | 2008-05-09 |
Multiple Sclerosis (2) · Graves Ophthalmopathy (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Biogen (1) · Fred Lublin (1) · Göteborg University (1) · Masonic Cancer Center, University of Minnesota (1)
United States (3) · Sweden (1)
Fred Lublin, MD (1) · Helena Filipsson, Ass Prof (1) · Jeffrey A. Cohen, MD (1) · Sherman Holtan, MD (1)